Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $3.29 and traded as low as $3.05. Hypera shares last traded at $3.05, with a volume of 710 shares traded.
Hypera Stock Down 1.0 %
The company’s 50-day simple moving average is $3.29 and its 200 day simple moving average is $4.48. The company has a market capitalization of $1.93 billion, a P/E ratio of 5.29 and a beta of 1.01.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Read More
- Five stocks we like better than Hypera
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Manufacturing Stocks Investing
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
